Robert Scott Mc Dowell Myo Kardia Inc (MYOK) insider trading activity
Robert Scott Mc Dowell is Chief Scientific Officer of MyoKardia Inc. Currently has a direct ownership of 0 shares of MYOK, which is worth approximately $0. The most recent transaction as insider was on Nov 17, 2020, when has been sold 36,616 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
RSM
Robert Scott Mc Dowell
Chief Scientific Officer
Brisbane, CA